Bio Sequence

A Retrieval Scheme for Any Combination of Antibodies Light Chains, Heavy Chains, and CDR

6 September 2023
2 min read

Patsnap Bio Sequence Database can retrieve antibody light and heavy chains, CDR sequence, and any CDR combination.

On the one hand, one or more light and heavy chain CDR sequences can be retrieved by manual input. On the other hand, by inputting the full-length sequence of light and heavy chains and clicking on the encoding rules, the corresponding CDR sequence can be automatically filled in (see Figure 1).

图形用户界面, 应用程序, Word

描述已自动生成

Moreover, on the "View Sources" page of the sequence retrieval results, you can see the public source results of any CDR sequence combination, and you can view the corresponding patents/documents by clicking on the results. If you want to see the common public patents of HCDR2, HCDR3, LCDR2, and LCDR3 (see Figure 2), save patents 5216 and 5228 to two folders in the workspace, and then take the intersection of the two folders to get the common public results (see Figure 3). The same method can be used to find common public patents of other combinations.

电脑屏幕截图

描述已自动生成

It is important to note that Patsnap Bio is the most extensive sequence search platform for the Patsnap database. It incorporates AI with human-curated data for comprehensive handling of protein and nucleotide sequence data plucked from global patents, biological periodicals, and public repositories. Essential biological sequences are manually annotated illuminating structural modifications to provide the most accurate sequence data and boost sequence retrieval efficiency.

Free registration is currently available to utilize the Bio biological sequence database: https://bio-patsnap-com.libproxy1.nus.edu.sg. Act now to expedite your sequence search tasks.

Bayer has high expectations for Kerendia in treating heart failure
Latest Hotspot
4 min read
Bayer has high expectations for Kerendia in treating heart failure
6 September 2023
Bayer’s Kerendia (finerenone)  had gained approval for usage in managing chronic kidney diseases affiliated with type 2 diabetes two summers ago.
Read →
An Overview of Boehringer Ingelheim’s Pipeline|R&D Progress|Target
R&D Pipeline
5 min read
An Overview of Boehringer Ingelheim’s Pipeline|R&D Progress|Target
6 September 2023
Boehringer Ingelheim GmbH is a pharmaceutical organization that was founded in 1885 and is headquartered in Rheinland-Pfalz, Germany.
Read →
Stallerges Greer Announces Global Nestle Contract for Palforzia® Peanut Allergy Treatment
Latest Hotspot
3 min read
Stallerges Greer Announces Global Nestle Contract for Palforzia® Peanut Allergy Treatment
6 September 2023
Stallerges Greer has disclosed a contract with Nestle regarding the use of Palforzia ® A global agreement to treat peanut allergies.
Read →
Ketanserin: Detailed Review of its Transformative R&D Success
Drug Insights
5 min read
Ketanserin: Detailed Review of its Transformative R&D Success
6 September 2023
This article summarized the latest R&D progress of Ketanserin, the Mechanism of Action for Ketanserin, and the drug target R&D trends for Ketanserin.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.